Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

Mechanisms of T cell-mediated cytotoxicity remain poorly defined at the molecular level. To investigate some of these mechanisms, we used as target cells, on the one hand, thymocytes from lpr and gld mouse mutants, and on the other hand, L1210 cells transfected or not with the apoptosis-inducing Fas molecule. These independent mutant or transfectant-based approaches both led to the conclusion that Fas was involved in the Ca(2+)-independent component of cytotoxicity mediated by at least two sources of T cells, namely nonantigen-specific in vitro activated hybridoma cells, and antigen-specific in vivo raised peritoneal exudate lymphocytes. Thus, in these cases, T cell-mediated cytotoxicity involved transduction via Fas of the target cell death signal.

[1]  M. Pawlita,et al.  Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. , 1992, The Journal of biological chemistry.

[2]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[3]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[4]  L. Owen-Schaub,et al.  DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. , 1992, Cellular immunology.

[5]  N. Copeland,et al.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.

[6]  L. David Tomei,et al.  Apoptosis: The Molecular Basis of Cell Death , 1991 .

[7]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[8]  J. D. Young,et al.  Cell Death Mechanisms and the Immune System , 1991, Immunological reviews.

[9]  J. Cohen,et al.  Programmed cell death in the immune system. , 1991, Advances in immunology.

[10]  N. Yamamoto,et al.  Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. D. Marshall,et al.  Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. , 1990, The Journal of experimental medicine.

[12]  M. Suthanthiran,et al.  A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells , 1990, The Journal of experimental medicine.

[13]  P. Möller,et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.

[14]  J. D. Young,et al.  Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Y. Tsao,et al.  Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both. , 1988, Journal of immunology.

[16]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[17]  T. Decker,et al.  Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. , 1987, Journal of immunology.

[18]  F. Dumont,et al.  Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. , 1986, Journal of immunology.

[19]  G. Klein,et al.  YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. , 1985, Journal of immunology.

[20]  G. Berke,et al.  T-Lymphocyte-mediated cytolysis as an excitatory process of the target. I. Evidence that the target cell may be the site of Ca2+ action. , 1985, Cellular immunology.

[21]  L. Olson,et al.  DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system. , 1985, Advances in experimental medicine and biology.

[22]  W. Fiers,et al.  Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid , 1984, The Journal of experimental medicine.

[23]  E. Eicher,et al.  A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice , 1984, The Journal of experimental medicine.

[24]  P. Corthésy,et al.  Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity , 1982, Nature.

[25]  J. Russell,et al.  Mechanisms of immune lysis. III. Characterization of the nature and kinetics of the cytotoxic T lymphocyte-induced nuclear lesion in the target. , 1982, Journal of immunology.

[26]  A. Wyllie.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.

[27]  H. Hengartner,et al.  Fine specificity of a continuously growing killer cell clone specific for H‐Y antigen , 1979, European journal of immunology.

[28]  P. Golstein.  Sensitivity of cytotoxic T cells to T-cell mediated cytotoxicity , 1974, Nature.

[29]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.